INNO.CN
Price:
$7.5
Market Cap:
$24.26M
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corpora...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-09-25
Stock Exchange
CNQ
Ticker
INNO.CN
According to InnoCan Pharma Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -6.58. This represents a change of -79.97% compared to the average of -32.85 of the last 4 quarters.
The mean historical PE Ratio of InnoCan Pharma Corporation over the last ten years is -12.30. The current -6.58 PE Ratio has changed 5.25% with respect to the historical average. Over the past ten years (40 quarters), INNO.CN's PE Ratio was at its highest in in the March 2022 quarter at 68.37. The PE Ratio was at its lowest in in the December 2024 quarter at -87.38.
Average
-12.30
Median
-12.46
Minimum
-21.73
Maximum
-2.74
Discovering the peaks and valleys of InnoCan Pharma Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 403.00%
Maximum Annual PE Ratio = -2.74
Minimum Annual Increase = -81.69%
Minimum Annual PE Ratio = -21.73
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -21.73 | 74.35% |
| 2023 | -12.46 | 25.83% |
| 2022 | -9.90 | -28.05% |
| 2021 | -13.76 | 403.00% |
| 2020 | -2.74 | -30.67% |
| 2019 | -3.95 | -81.69% |
The current PE Ratio of InnoCan Pharma Corporation (INNO.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.70
5-year avg
-12.12
10-year avg
-12.30
InnoCan Pharma Corporation’s PE Ratio is less than Decibel Cannabis Company Inc. (7.75), less than Vext Science, Inc. (-3.25), less than Planet 13 Holdings Inc. (-1.40), greater than C21 Investments Inc. (-12.71), less than iAnthus Capital Holdings, Inc. (21.42), less than MariMed Inc. (-2.94), greater than BioNxt Solutions Inc. (-11.43), less than Medexus Pharmaceuticals Inc. (163.47), greater than Sona Nanotech Inc. (-17.02), less than Leef Brands Inc. (-1.67),
| Company | PE Ratio | Market cap |
|---|---|---|
| 7.75 | $63.45M | |
| -3.25 | $69.39M | |
| -1.40 | $95.98M | |
| -12.71 | $51.91M | |
| 21.42 | $68.17M | |
| -2.94 | $61.24M | |
| -11.43 | $73.09M | |
| 163.47 | $86.24M | |
| -17.02 | $53.11M | |
| -1.67 | $49.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoCan Pharma Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InnoCan Pharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is InnoCan Pharma Corporation's PE Ratio?
How is the PE Ratio calculated for InnoCan Pharma Corporation (INNO.CN)?
What is the highest PE Ratio for InnoCan Pharma Corporation (INNO.CN)?
What is the 3-year average PE Ratio for InnoCan Pharma Corporation (INNO.CN)?
What is the 5-year average PE Ratio for InnoCan Pharma Corporation (INNO.CN)?
How does the current PE Ratio for InnoCan Pharma Corporation (INNO.CN) compare to its historical average?